NCT03195556NARecruitingAccepts Healthy Volunteers

Augmentation of Limb Perfusion With Contrast Ultrasound

Oregon Health and Science University

Start Date

6/18/2018

Completion Date

12/1/2019

Summary

Our laboratory has discovered that ultrasound (US) imaging together with clinically approved microbubble ultrasound contrast agents can augment limb tissue perfusion. These observations have been made in mice with and without peripheral artery disease (PAD), and also in humans where high power contrast enhanced ultrasound (CEU) was used to measure perfusion but was found also to augment perfusion by almost 2-fold. The latter human studies were performed with ultrasound protocols designed for perfusion imaging and not for flow augmentation. In this study, we will measure the degree to which limb perfusion is augmented with specific therapeutic CEU settings that are still within the FDA-approved limits with regards to US power and contrast dosing.

Eligibility Criteria

Age Range: 19 years to 99 years

Inclusion Criteria: * Age ≥18 y.o. * For PAD subjects: known history of unilateral or bilateral PAD diagnosed by reduced ankle-brachial index or angiography and a Rutherford symptom class of 4-6. Exclusion Criteria: 1. Major medical illness other than PAD affecting the limb (muscle disease, blood diseases that influence flow or rheology, severe heart failure \[NYHA class IV or LVEF \<30%\]). 2. Pregnant or lactating females 3. Hypersensitivity to any ultrasound contrast agent 4. Known atrial septal defect or large right to left shunt. 5. Hemodynamic instability (hypotension with systolic BP \<90 mm Hg, need for vasopressors) 6. Evidence for ongoing myocardial ischemia 7. For normal controls, any known structural non-arrhythmic cardiovascular disease (coronary artery disease, heart failure, moderate or greater valve disease).

Interventions

DEVICE

Ultrasound

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Peripheral Arterial Disease

Locations

OHSU

Portland, Oregon 97239

United States